- Investing Ideas
- /
- French Potential Opportunities
French Potential Opportunities
UPDATED Nov 27, 2023
Companies that are potentially undervalued based on future cash flows and market ratios.
137 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FRVIAForvia | €17.22 | 2.2% | 11.9% | €3.4b | €28.06 | PB0.8x | E47.4% | 0% | Automobiles | ||
| MDMMaisons du Monde | €4.55 | -7.7% | -60.8% | €167.5m | €7.90 | PE6.3x | E3.0% | 6.6% | Retail | ||
| INFInfotel | €45.60 | -2.8% | -15.6% | €314.1m | €55.34 | PE15.7x | E6.3% | 4.4% | Software | ||
| SFPIGROUPE SFPI | €1.56 | -2.6% | -29.3% | €143.7m | €3.80 | PE8.2x | E25.1% | 3.2% | Tech | ||
| RXLRexel | €21.64 | 1.8% | 16.5% | €6.5b | €24.83 | PE7.3x | E-3.1% | 5.5% | Capital Goods | ||
| ALOAlstom | €11.92 | -4.3% | -51.5% | €4.6b | €22.03 | PB0.5x | E89.3% | 2.1% | Capital Goods | ||
| TFITF1 | €6.91 | 1.0% | -4.1% | €1.5b | €9.89 | PE8.8x | E15.4% | 7.2% | Media | ||
| ALICAIcape Holding | €10.00 | -8.3% | -34.9% | €80.9m | €18.50 | PE9.4x | E16.5% | 2.0% | Tech | ||
| DBGDerichebourg | €4.90 | 8.1% | -3.9% | €780.7m | €7.92 | PE4.1x | E5.3% | 6.5% | Commercial Services | ||
| TKTTTarkett | €9.16 | 0.9% | -25.2% | €599.4m | €10.00 | PB0.7x | S0.4% | 0% | Capital Goods | ||
| ALTAAltarea | €69.90 | 0.1% | -49.9% | €1.4b | €80.00 | PB0.7x | E63.6% | 14.3% | Real Estate | ||
| ALMRBMr.Bricolage | €8.10 | 1.0% | -1.2% | €82.9m | €16.00 | PE4.2x | E-0.4% | 0% | Retail | ||
| VKVallourec | €13.50 | 4.0% | 26.2% | €3.1b | €19.57 | PE6.6x | E4.5% | 0% | Energy | ||
| IPNIpsen | €102.60 | -1.6% | -5.7% | €8.5b | €127.95 | PE20.9x | E13.1% | 1.2% | Pharmaceuticals & Biotech | ||
| GBTGuerbet | €18.80 | 5.6% | 11.5% | €237.3m | €19.08 | PB0.6x | E101.1% | 2.7% | Healthcare | ||
| ALVALValbiotis | €5.54 | -5.1% | 50.5% | €68.7m | €11.83 | PS15.7x | E73.6% | n/a | Pharmaceuticals & Biotech | ||
| ALMOUMoulinvest | €21.80 | -4.4% | -39.7% | €66.0m | €40.00 | PE4.2x | E-7.6% | 4.6% | Materials | ||
| RUIRubis | €22.16 | 0.9% | -8.8% | €2.3b | €33.30 | PE8.7x | E12.6% | 8.7% | Utilities | ||
| ALVETTheraVet | €1.61 | -1.2% | -48.6% | €5.2m | €12.50 | PS4x | E42.3% | n/a | Pharmaceuticals & Biotech | ||
| TEPTeleperformance | €128.95 | -2.5% | -39.7% | €7.7b | €192.27 | PE11.9x | E16.7% | 3.0% | Commercial Services | ||
| ORAPOrapi | €6.44 | 0.3% | 35.3% | €42.0m | €6.50 | PB0.8x | E147.1% | 0% | Materials | ||
| IDIPIDI | €64.80 | 1.3% | 30.9% | €453.6m | €78.00 | PE3.6x | E-16.3% | 3.9% | Diversified Financials | ||
| SOPSopra Steria Group | €189.40 | 0.5% | 31.1% | €3.8b | €236.26 | PE15.4x | E16.9% | 2.3% | Software | ||
| VCTVicat | €32.00 | -0.8% | 37.3% | €1.4b | €34.86 | PE8.2x | E7.6% | 5.2% | Materials |